This review concluded that there was preliminary evidence in favour of the effectiveness of isoxsuprine in prolonging pregnancy in women at risk of abortion or premature delivery. This was based on the synthesis of small, old studies of unclear quality. Given multiple concerns over the evidence base and the review methods, the authors' conclusion cannot be regarded as reliable.
Included studies assessed the use of isoxsuprine as either acute (intravenous administration) or maintenance (oral or intramuscular administration) therapy or as a combination of the two. In the small number of controlled studies, a placebo comparator was used. The age of women in the included studies ranged from 16 to 42 years. Five studies included only women at risk of abortion. All the included studies were published between 1961 and 1981.
The authors did not state how the studies were selected for the review.
Assessment of study quality
Two reviewers independently assessed the studies for validity. It appeared that this was done according to guidelines in the Cochrane Handbook.
Data extraction
Outcome data were extracted and classified as positive or negative. Outcomes considered positive were those reported as "positive", "good" "term delivery", "pregnancy ongoing", "patient discharged", "at home", "at least eighth month" and delay of delivery by more than one week. Outcomes considered negative were those reported as "negative", "abortion", "premature delivery", "baby died" or a delay of delivery by up to one week. Durations of delays in delivery were also extracted.
The authors did not state how many reviewers performed the data extraction.
Methods of synthesis
Fisher's exact test was used to compare data from the groups in the double-blind controlled studies and to compare positive versus negative outcomes across studies. One controlled study was excluded from analysis because the sample size was considered to be too small. Data on delay of pregnancy was analyzed by the Kruskal-Wallis test.
